PharmiWeb.com - Global Pharma News & Resources
07-Jan-2019

Hemophilia A Therapeutics - Global Market Outlook to 2023 with Bayer, CSL, Novo Nordisk, Pfizer and Shire Dominating - ResearchAndMarkets.com

The "Global Hemophilia A Therapeutics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

The hemophilia A therapeutics market will register a CAGR of almost 7% by 2023.

Emerging novel convenient approaches to drive market growth

Several novel therapies are emerging in the global hemophilia A therapeutics market. These therapies offer long lasting therapeutics benefits and some of the m possess potential to cure this disorder.

Rising prevalence of hemophilia A

Hemophilia A is a rare genetic disorder, and the incidence of this disorder is gradually increasing. Hemophilia A accounts for about 80% of cases globally and mainly affects men.

High costs of hemophilia A therapeutics

High costs associated with drugs that treat hemophilia A are one of the biggest challenges faced by the market.

Key Players

  • Bayer
  • CSL
  • Novo Nordisk
  • Pfizer
  • Shire

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Recombinant therapies - Market size and forecast 2018-2023
  • Plasma-derived therapies - Market size and forecast 2018-2023
  • Hormonal therapies - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY TYPE

  • On demand treatment
  • Prophylactic treatment
  • Inhibitor treatment

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Bayer
  • CSL
  • Novo Nordisk
  • Pfizer
  • Shire

For more information about this report visit https://www.researchandmarkets.com/research/bkvl62/hemophilia_a?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190107005513/en/

Editor Details

Last Updated: 07-Jan-2019